Vinati Organics
- P/E
- 20.75
Key Fundamentals
MicrocapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Standalone · TTM
- ROCE
- 21.40%
- Debt to Equity
- 0.00
- EPS (TTM)
- ₹48.09
- Book Value
- ₹314.54
- Market Cap
- —
- P/E (TTM)
- 20.75
- P/B
- 3.17
- ROE
- 16.20%
- Dividend Yield
- 0.89%
- EBITDA
- ₹707 Cr
- 52W High
- ₹1,684.90
- 52W Low
- ₹950.05
- Volume
- 0
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| ₹998.00 | 20.75 | ₹9,963 Cr | 3.17 | 0.89% | 16.20% | 21.40% | ₹2,384 Cr | ₹499 Cr | |
| Median 8 companies | ₹1,559.55 | 43.80 | ₹20,474 Cr | 4.68 | 0.36% | 10.66% | 13.40% | ₹6,136 Cr | ₹692 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 98/100
Category scores
- Quality
- 80
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 60
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 27
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 86
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 10
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 45
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
3- Company has reduced debt.
- Company is almost debt free.
- Company has been maintaining a healthy dividend payout of 19.8%
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 5 | 2 |
| Oscillators | Neutral | 2 | 5 | 2 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Neutral
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 32.63
- Neutral
- MACD (12,26,9)
- −58.62
- Bearish
- SMA (50)
- 1,190.97
- Bearish
- SMA (200)
- 1,327.03
- Bearish
As of
Analyst Rating
9 of 12 analysts rate Buy, 2 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +13.45% |
|---|---|
| 5Y | +18.49% |
| 3Y | +2.55% |
| 1Y | −0.89% |
| TTM | +5.25% |
Net profit
| 10Y | +13.97% |
|---|---|
| 5Y | +12.65% |
| 3Y | +5.21% |
| 1Y | +17.59% |
| TTM | +12.64% |
Operating cash flow
| 10Y | +14.16% |
|---|---|
| 5Y | +23.45% |
| 3Y | +6.77% |
| 1Y | +27.13% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.89 pp |
|---|---|
| 5Y | −6.08 pp |
| 3Y | +3.19 pp |
| 1Y | +4.81 pp |
| TTM | +1.85 pp |
Revenue by year
| Mar 2017 | ₹641 Cr |
|---|---|
| Mar 2018 | ₹730 Cr |
| Mar 2019 | ₹1,128 Cr |
| Mar 2020 | ₹1,029 Cr |
| Mar 2021 | ₹954 Cr |
| Mar 2022 | ₹1,616 Cr |
| Mar 2023 | ₹2,066 Cr |
| Mar 2024 | ₹1,900 Cr |
| Mar 2025 | ₹2,248 Cr |
| Mar 2026 | ₹2,228 Cr |
Net profit by year
| Mar 2017 | ₹140 Cr |
|---|---|
| Mar 2018 | ₹144 Cr |
| Mar 2019 | ₹282 Cr |
| Mar 2020 | ₹334 Cr |
| Mar 2021 | ₹269 Cr |
| Mar 2022 | ₹347 Cr |
| Mar 2023 | ₹419 Cr |
| Mar 2024 | ₹323 Cr |
| Mar 2025 | ₹415 Cr |
| Mar 2026 | ₹488 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Vinati Organics is a ₹14,215 crore specialty chemicals company trading at a PE of 30.6x, below its 4-quarter average of ~39x. The company delivered 18% revenue growth and 25% PAT growth in FY25 with near-zero debt (debt-to-equity of 0.02), but its stock has declined 19% over the past year and sales CAGR over 3 years has moderated to just 3%.
- Dominant global position in ATBS with 60-65% market share, providing strong pricing power and recurring demand from oil & gas and water treatment sectors
- Near debt-free balance sheet with debt-to-equity of just 0.02, giving financial flexibility for capacity expansion without dilution
- FY25 revenue grew 18% YoY to ₹2,292 crore and PAT rose 25% to ₹405 crore, showing strong recovery from FY24 slowdown
- ATBS capacity expanded 50% to 60,000 MTPA with ₹300 crore capex, with the new 10,000-tonne line already fully booked upon commissioning
- EBITDA margin improved to 27.3% in FY25 (up from ~24% in FY24), with management guiding sustainable blended margins of 26-27%
- Management guidance of 20% revenue growth for the next three years driven by ATBS and Antioxidants volume ramp-up
- Current PE of 30.6x is 22% below its recent 4-quarter average of 39.2x, suggesting valuation has de-rated from peak levels
- Diversification into antioxidants showing traction with 70% volume surge in FY25, reducing single-product concentration risk
- Stock has declined 19% over the past 1 year and delivered a negative 10% CAGR over 3 years, significantly underperforming broader markets
- 3-year compounded sales CAGR of only 3% indicates prolonged revenue stagnation between FY22-FY25, despite FY25 recovery
- FY26 full-year revenue declined 0.95% YoY to ₹22.27 billion, suggesting the FY25 recovery was short-lived
- ROE has declined from 19% (10-year average) to 16% last year, indicating diminishing returns on equity capital over time
- PE of 30.6x remains elevated for a company delivering only 5% TTM sales growth and 13% TTM profit growth
- Heavy concentration in ATBS (40% of sales) exposes the company to cyclicality in oil & gas and oilfield chemicals demand
- Q4 FY26 revenue fell 7% YoY to ₹604 crore and PAT in Q1 FY27 decreased 12% QoQ to ₹109 crore, indicating recent quarterly weakness
- Dividend yield of just 0.57% with a 19.8% payout ratio offers limited income return relative to risk-free alternatives
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Vinati Organics is delivering strong topline growth with revenue up ~28% YoY, though profit growth is more modest at 4.5-9.5%, suggesting some margin compression. The company has guided 15% volume growth and 26-27% EBITDA margins for FY27, with the Veeral Organics subsidiary acting as an additional revenue catalyst from March 2027. No visible headwinds in recent news, and the trend is improving with a clear H2-weighted recovery expected.
- Q1FY27 revenue surges 28.4% Jul 30
Consolidated net profit rose 4.5% YoY to ₹108.86 crore for Q1FY27, driven by a 28.4% revenue surge to ₹695.91 crore.
- Q1FY26 profit up 9.5% YoY Jul 29
Standalone net profit rose 9.5% YoY to ₹123.56 crore for Q1FY26, with revenue jumping 28.7% to ₹697.75 crore.
- EBITDA margin guidance 26-27% FY27 Jul 30
Management guided EBITDA margin of 26-27% for FY27, with H2 expected to be stronger than H1, signaling a back-ended margin recovery.
- 15% volume growth, Veeral ramp-up Jul 30
Company guided ~15% volume growth for FY27. Veeral Organics is expected to add ₹400-500 crore revenue, commencing operations in March 2027 at ~₹150 crore initial revenue.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 439 | 463 | 448 | 550 | 525 | 553 | 522 | 648 | 542 | 546 | 529 | 611 | 698 | 668 |
| Expenses | 338 | 358 | 333 | 400 | 400 | 419 | 379 | 465 | 376 | 368 | 368 | 427 | 516 | 538 |
| Operating Profit | 100 | 105 | 115 | 150 | 125 | 134 | 143 | 184 | 166 | 179 | 161 | 183 | 181 | 130 |
| OPM % | 23% | 23% | 26% | 27% | 24% | 24% | 27% | 28% | 31% | 33% | 30% | 30% | 26% | 19% |
| Other Income | 10 | 11 | 9 | 10 | 9 | 22 | 7 | 6 | 7 | 16 | 9 | 20 | 9 | 13 |
| Interest | 0.27 | 0.27 | 1 | 1 | 0.45 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 17 | 17 | 19 | 19 | 20 | 21 | 20 | 20 | 21 | 22 | 24 | 25 | 25 | 26 |
| PBT | 93 | 97 | 103 | 140 | 114 | 136 | 129 | 169 | 151 | 173 | 145 | 179 | 165 | 116 |
| Tax % | 25% | 25% | 25% | 25% | 25% | 22% | 26% | 25% | 26% | 25% | 25% | 23% | 25% | 25% |
| Net Profit | 69 | 72 | 77 | 104 | 86 | 106 | 96 | 128 | 113 | 129 | 108 | 138 | 124 | 87 |
| EPS (₹) | 6.75 | 7.05 | 7.49 | 10.08 | 8.3 | 10.24 | 9.22 | 12.31 | 10.88 | 12.45 | 10.46 | 13.26 | 11.92 | — |
Sep 2026: from the results filed on 30 Oct 2026, ahead of the full statement, so some rows are blank.
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 772 | 631 | 641 | 730 | 1,128 | 1,029 | 954 | 1,616 | 2,066 | 1,900 | 2,248 | 2,228 | 2,384 |
| Expenses | 580 | 424 | 423 | 531 | 703 | 614 | 601 | 1,180 | 1,493 | 1,429 | 1,662 | 1,539 | 1,680 |
| Operating Profit | 192 | 207 | 218 | 198 | 425 | 415 | 353 | 435 | 573 | 471 | 587 | 689 | 704 |
| OPM % | 25% | 33% | 34% | 27% | 38% | 40% | 37% | 27% | 28% | 25% | 26% | 31% | 30% |
| Other Income | 9 | 6 | 12 | 31 | 30 | 45 | 26 | 61 | 52 | 39 | 44 | 53 | 54 |
| Interest | 10 | 8 | 3 | 2 | 2 | 2 | 1 | 2 | 3 | 5 | 0.52 | 0.41 | 0 |
| Depreciation | 18 | 19 | 22 | 23 | 27 | 33 | 43 | 45 | 59 | 73 | 81 | 92 | 96 |
| PBT | 174 | 187 | 206 | 203 | 425 | 425 | 335 | 449 | 563 | 432 | 548 | 649 | 662 |
| Tax % | 33% | 29% | 32% | 29% | 34% | 21% | 20% | 23% | 26% | 25% | 24% | 25% | — |
| Net Profit | 116 | 132 | 140 | 144 | 282 | 334 | 269 | 347 | 419 | 323 | 415 | 488 | 499 |
| EPS (₹) | 11.22 | 12.75 | 13.59 | 14 | 27.48 | 32.48 | 26.2 | 33.73 | 40.78 | 31.19 | 40.05 | 47.05 | 48.09 |
| Div. Payout % | 16% | 16% | 2% | 16% | 13% | 17% | 23% | 19% | 17% | 22% | 19% | 18% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Reserves | 424 | 530 | 670 | 786 | 1,041 | 1,269 | 1,533 | 1,851 | 2,203 | 2,454 | 2,796 | 3,206 |
| Borrowings | 65 | 42 | 2 | 15 | 4 | 0 | 2 | 28 | 35 | 5 | 63 | 0 |
| Other Liabilities | 100 | 104 | 139 | 168 | 173 | 163 | 188 | 260 | 335 | 358 | 394 | 405 |
| Total Liabilities | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,621 |
| Fixed Assets | 327 | 382 | 468 | 457 | 475 | 751 | 757 | 874 | 1,159 | 1,330 | 1,382 | 1,612 |
| CWIP | 20 | 25 | 7 | 35 | 191 | 31 | 55 | 306 | 229 | 246 | 298 | 126 |
| Investments | 3 | 3 | 62 | 132 | 96 | 227 | 289 | 98 | 256 | 237 | 523 | 937 |
| Other Assets | 249 | 278 | 284 | 356 | 465 | 434 | 633 | 872 | 940 | 1,014 | 1,059 | 946 |
| Total Assets | 599 | 687 | 821 | 980 | 1,228 | 1,443 | 1,734 | 2,150 | 2,584 | 2,827 | 3,263 | 3,621 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 113 | 167 | 130 | 138 | 200 | 416 | 219 | 127 | 516 | 338 | 494 | 628 |
| Investing | −53 | −72 | −27 | −39 | −243 | −197 | −198 | −256 | −333 | −353 | −480 | −485 |
| Financing | −75 | −50 | −45 | −30 | −40 | −109 | −3 | −46 | −61 | −106 | −15 | −141 |
| Net Cash Flow | −16 | 45 | 59 | 70 | −83 | 109 | 18 | −175 | 121 | −122 | 0 | 2 |
| Free Cash Flow | 56 | 91 | 32 | 92 | −6 | 279 | 137 | −40 | 216 | 109 | 308 | 491 |
| CFO/OP | 86 | 103 | 84 | 95 | 77 | 124 | 79 | 54 | 113 | 90 | 100 | 111 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 66 | 80 | 89 | 79 | 72 | 106 | 102 | 82 | 102 | 96 | 87 |
| Inventory Days | 44 | 55 | 79 | 79 | 64 | 79 | 115 | 85 | 79 | 72 | 66 | 99 |
| Days Payable | 17 | 28 | 40 | 61 | 37 | 47 | 62 | 52 | 41 | 36 | 43 | 40 |
| Cash Conversion Cycle | 87 | 94 | 119 | 107 | 106 | 104 | 158 | 136 | 120 | 137 | 119 | 146 |
| Working Capital Days | 58 | 60 | 118 | 113 | 111 | 97 | 138 | 144 | 109 | 140 | 107 | 115 |
| ROCE % | 38% | 36% | 33% | 28% | 46% | 37% | 24% | 26% | 27% | 19% | 21% | 21% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vinati Organics insights
68 extracted metrics across FY11–FY27.
Documents
- Q4 FY26 concall · May 2026Transcript
- Q4 FY25 concall · May 2025Transcript Recording
- Q1 FY25 concall · Aug 2024Transcript
- Q1 FY25 concall · Aug 2024Transcript
- Q4 FY24 concall · May 2024Transcript Recording
- 8 Oct 2026
- 6 Oct 2025
- 9 Oct 2024
- 9 Oct 2023
- 6 Oct 2022
- General announcements 2 Nov 2026
Frequently Asked Questions about Vinati Organics
What does Vinati Organics Ltd do?
Where is Vinati Organics Ltd (VINATIORGA) listed?
Which sector does Vinati Organics Ltd belong to?
What is the PE ratio of Vinati Organics Ltd?
What is the 52-week high and low of Vinati Organics Ltd?
Does Vinati Organics Ltd pay dividends?
What is the Return on Equity (ROE) of Vinati Organics Ltd?
Company Information
Vinati Organics Ltd is an integrated B2B manufacturer of the specialty monomers, aromatics, butyl phenols, antioxidants, polymers and inorganic /specialty intermediates, with four manufacturing sites in Maharashtra and exports to global chemical customers.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VINATIORGA.md for Vinati Organics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.